| | 444722-95-6 Basic information More.. |
| Product Name: | NU6102 | | Synonyms: | 6-CYCLOHEXYLMETHOXY-2-(4'-SULFAMOYLANILINO)PURINE;CDK1/2 INHIBITOR II;NU6102;O6-CYCLOHEXYLMETHYL-2-(4-SULFAMOYLANILINO)PURINE;4-[[6-(Cyclohexylmethoxy)-1H-purin-2-yl]amino]benzenesulfonamide;Benzenesulfonamide, 4-[[6-(cyclohexylmethoxy)-9H-purin-2-yl]amino]-;4-[[6-(cyclohexylmethoxy)-9H-purin-2-yl]amino]-benzenesulfonamide | | CAS: | 444722-95-6 | | MF: | C18H22N6O3S | | MW: | 402.47 | | EINECS: | | | Mol File: | Mol File |  |
Use
NU6102 is a known potent inhibitor of CDK1, CDK2 and CDK7. Cyclin-dependent kinases play a key role in the regulation of cell division which is controlled by the phosphorylation of distinct substrates
in different phases of the cell cycle. In any circumstance where the cell cycle is deregulated, cyclin-dependent kinases activities are altered. Since NU6102 is known to exert inhibitory activities a
gainst CDKs, it has potential to act as a control in the cell cycle, especially in various cancers. NU6102 is known to be an anticancer agent use to repress the expression of breast cancer cells.
|
|
444722-95-6
Recommend Suppliers |
|